Literature DB >> 9578315

Life-threatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation: successful rechallenge after desensitization.

H Kook1, K M Kim, S H Choi, B S Choi, H J Kim, S Y Chung, S J Choi, T J Hwang.   

Abstract

Carboplatin hypersensitivity has rarely been reported in patients receiving repeated cycles of therapy, but has not been reported in transplant settings. We report a case of carboplatin hypersensitivity during conditioning for autologous PBSC transplantation. The patient suddenly developed chest tightness, hemoptysis, hypoxia and hypotension, resulting in a transient myocardial ischemia. The pathophysiologic mechanism for the event seemed to be non-immune-mediated direct histamine release given the lack of prior exposure to platinum. Contrary to advice not to continue further treatment with carboplatin by some authors, we successfully desensitized the patient and subsequently gave more carboplatin as a part of conditioning. Awareness of carboplatin as one of the causes of hypersensitivity may help avoid further problems either by substitution or desensitization, along with premedications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9578315     DOI: 10.1038/sj.bmt.1701161

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  6 in total

Review 1.  Clinical immunology review series: an approach to desensitization.

Authors:  M T Krishna; A P Huissoon
Journal:  Clin Exp Immunol       Date:  2010-12-22       Impact factor: 4.330

2.  Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.

Authors:  Nektaria Makrilia; Ekaterini Syrigou; Ioannis Kaklamanos; Leonidas Manolopoulos; Muhammad Wasif Saif
Journal:  Met Based Drugs       Date:  2010-09-20

3.  The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment.

Authors:  Roisin O'Cearbhaill; Qin Zhou; Alexia Iasonos; Martee L Hensley; William P Tew; Carol Aghajanian; David R Spriggs; Stuart M Lichtman; Paul J Sabbatini
Journal:  Gynecol Oncol       Date:  2009-11-27       Impact factor: 5.482

4.  Readministration of Platinum Agents in Recurrent Ovarian Cancer Patients Who Developed Hypersensitivity Reactions to Carboplatin.

Authors:  Chikage Narui; Hiroshi Tanabe; Jason S Shapiro; Yoko Nagayoshi; Takenori Maruta; Momoko Inoue; Yukihiro Hirata; Hiromi Komazaki; Hirokuni Takano; Shigeki Niimi; Seiji Isonishi; Aikou Okamoto
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

Review 5.  Prevention and management of antineoplastic-induced hypersensitivity reactions.

Authors:  K M Zanotti; M Markman
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

Review 6.  Hypersensitivity to Carboplatin in Children with Malignancy.

Authors:  Antonio Ruggiero; Daniela Rizzo; Martina Catalano; Giorgio Attinà; Riccardo Riccardi
Journal:  Front Pharmacol       Date:  2017-04-12       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.